Elucid Bioimaging Grant Awarded

vascuVis Inc., a wholly owned subsidiary of Elucid Bioimaging, has been awarded a two-year, $696,200 Small Business Innovation Research (SBIR) Phase II Grant from the National Science Foundation (NSF) for vascuCAP, it’s image processing system that employs a revolutionary approach in computational image processing using, “computer-aided prognostics,” to quantitatively evaluate the severity and composition of atherosclerotic plaque.